Focus Partners Advisor Solutions LLC Increases Stock Position in Bath & Body Works, Inc. $BBWI

Key Points

• Focus Partners Advisor Solutions LLC significantly increased its stake in Bath & Body Works by 143.3%, now holding 21,365 shares valued at $648,000.
• Analysts have mixed ratings on BBWI, with price targets ranging from $30.00 to $44.00, reflecting a consensus rating of "Moderate Buy" and an average price target of $41.62.
• Bath & Body Works recently declared a quarterly dividend of $0.20 per share, resulting in an annualized dividend yield of 2.5%.

Focus Partners Advisor Solutions LLC raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 143.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,365 shares of the company's stock after purchasing an additional 12,583 shares during the quarter. Focus Partners Advisor Solutions LLC's holdings in Bath & Body Works were worth $648,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. SVB Wealth LLC purchased a new stake in shares of Bath & Body Works in the first quarter valued at about $35,000. Golden State Wealth Management LLC raised its position in Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after acquiring an additional 642 shares during the last quarter. UMB Bank n.a. raised its position in shares of Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after buying an additional 596 shares during the last quarter. Ancora Advisors LLC acquired a new position in shares of Bath & Body Works in the fourth quarter valued at approximately $67,000. Finally, GKV Capital Management Co. Inc. acquired a new position in shares of Bath & Body Works in the first quarter valued at approximately $69,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Trading Down 7.5%

BBWI traded down $2.38 during trading on Friday, hitting $29.49. 10,016,218 shares of the company's stock were exchanged, compared to its average volume of 6,016,592. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The stock has a 50 day moving average price of $30.73 and a 200 day moving average price of $30.51. The firm has a market cap of $6.08 billion, a P/E ratio of 8.55, a price-to-earnings-growth ratio of 1.01 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the previous year, the firm earned $0.37 earnings per share. Bath & Body Works's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's payout ratio is currently 23.74%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on BBWI. Barclays upped their price target on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 14th. UBS Group dropped their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research report on Friday, August 29th. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the stock an "overweight" rating in a research report on Thursday, May 15th. Finally, The Goldman Sachs Group dropped their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average price target of $41.62.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.